Table 1.
Manipulation | MEF2 Reporter Positive Purkinje Cells (>4× Background) at t = 40 Min |
---|---|
Patched Cells | |
Vhold = −70 mV | 2/20 |
Depolarization | 3/20 |
Glutamate pulses | 3/20 |
Depolarization + glutamate pulses | 19/20 |
Vhold = −70mV (MEF2A+2D DKO) | 1/20 |
Depolarization + glutamate pulses (MEF2A+2D DKO) | 0/20 |
Non-patched Cells | |
No treatment | 3/100 |
MEF2-VP16-ER, 16–26 h tamoxifen | 100/100 |
MEF2-ΔDBD-VP16-ER, 16–26 h tamoxifen | 2/100 |
Tamoxifen, 16–26 h | 3/100 |
Phorbol-12,13-diacetate, 200 nM, 10 min | 97/100 |
MEF2D S444A | 2/100 |
A MEF2-activity reporter was created consisting of a triple repeat of the MEF2-response element (MRE) fused to a minimal promoter of the fos gene (that does not itself confer glutamate or depolarization responsiveness; Flavell et al., 2006) inserted in front of destabilized EGFP. Using a gene gun, this reporter plasmid was delivered to Purkinje cells, together with a separate dsRedexpress2 plasmid as a marker, 3 days after the culture was prepared. Measurements were then made 7–10 days after transfection.